Titles
- Enforcement policy for clinical electronic thermometers: guidance for industry and Food and Drug Administration staff1
- Enforcement policy for non-invasive remote monitoring devices used to support patient monitoring: guidance for industry and Food and Drug Administration staff1
- Enhanced drug distribution security at the package level under the Drug Supply Chain Security Act: guidance for industry1
- FDA could take stronger enforcement action against tobacco retailers with histories of sales to youth and other violations1
- FDA repeatedly adapted emergency use authorization policies to address the need for COVID-19 testing1
- FDA’s approach to overseeing online tobacco retailers needs improvement1
- FDA’s work with the tri-agency task force for emergency diagnostics helped labs implement COVID-19 tests1
- For Medicaid-enrolled children diagnosed with lead toxicity in five states, documentation reviewed for diagnoses and treatment services raises concerns1
- Fostering medical device improvement: FDA activities and engagement with the voluntary improvement program : guidance for industry and Food and Drug Administration staff1
- Four states reviewed received increased Medicaid COVID-19 funding even though they terminated some enrollees’ coverage for unallowable or potentially unallowable reasons1
- Georgia could better ensure that nursing homes comply with federal requirements for life safety, emergency preparedness, and infection control1
- Healthcare workforce1
- Healthy eating Rx: improving nutrition through health care1
- High rates of prior authorization denials by some plans and limited state oversight raise concerns about access to care in Medicaid managed care1
- Home health agencies failed to report over half of falls with major injury and hospitalization among their Medicare patients1
- Home health agencies rarely furnished services via telehealth early in the COVID-19 public health emergency1
- Home health agencies used multiple strategies to respond to the COVID-19 pandemic, although some challenges persist1
- Human prescription drug and biological products: labeling for dosing based on weight or body surface area for ready-to-use containers : “dose banding” : guidance for industry1
- In five states, there was no evidence that many children in foster care had a screening for sex trafficking when they returned after going missing1
- Inaccuracies in Medicare’s race and ethnicity data hinder the ability to assess health disparities1